Terms: = Bone cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Clinical Outcome
5 results:
1. Intensity-modulated Radiotherapy and Anal cancer: clinical outcome and Late Toxicity Assessment.
De Francesco I; Thomas K; Wedlake L; Tait D
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):604-10. PubMed ID: 27156162
[TBL] [Abstract] [Full Text] [Related]
2. Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy.
Yang J; Wang ZG; Cai HQ; Li YC; Xu YL
Asian Pac J Cancer Prev; 2013; 14(8):4595-8. PubMed ID: 24083708
[TBL] [Abstract] [Full Text] [Related]
3. High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes.
Cheng CL; Hou HA; Jhuang JY; Lin CW; Chen CY; Tang JL; Chou WC; Tseng MH; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
Br J Cancer; 2011 Sep; 105(7):975-82. PubMed ID: 21878936
[TBL] [Abstract] [Full Text] [Related]
4. Ewing and osteogenic sarcoma: evidence for multidisciplinary management.
Sciubba DM; Okuno SH; Dekutoski MB; Gokaslan ZL
Spine (Phila Pa 1976); 2009 Oct; 34(22 Suppl):S58-68. PubMed ID: 19829278
[TBL] [Abstract] [Full Text] [Related]
5. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients.
Faye RS; Aamdal S; Høifødt HK; Jacobsen E; Holstad L; Skovlund E; Fodstad Ø
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4134-9. PubMed ID: 15217950
[TBL] [Abstract] [Full Text] [Related]
